Genomewide m6A mapping uncovers dynamic changes in the m6A epitranscriptome of cisplatin-treated apoptotic HeLa cells.

To support researchers as they generate RNA datasets, Eclipsebio is proud to announce the 2025 Data Catalyst Award. Winners of the award will obtain matching funds to cover the cost of generating their control datasets.

Precision oncology uses information on the patient's own tumor to create personalized therapies, such as RNA cancer vaccines. These therapies train a patient's own immune system to attack cancer.

Designing RNA sequences that are stable and efficiently translated is complex. AI-driven tools are unlocking new possibilities, enabling optimized RNA design to accelerate therapeutic development.

Eclipsebio is proud to announce their sponsorship of the 2025 Gordon Research Conference on Decoding Microproteins Across Evolution and Disease in Barcelona.